hsa-mir-324: Hsa-mir-324 is a microRNA that has been found to be associated with progression pathways in triple-negative breast cancer (TNBC) [PMC4633580]. A study identified three miRNAs, including hsa-mir-324, to be linked to TNBC progression pathways, but did not integrate these miRNAs with TNBC genes alone or compare them to normal tissue or lymph node metastases [PMC4633580]. Another study found that 4-AAQB, a compound, enhanced the anticancer effect of FOLFOX (folinate, fluorouracil, and oxaliplatin) by re-expressing hsa-mir-324 that was inhibited by SOD2 and suppressing SOD2-mediated tumorigenicity [PMC9164036]. Hsa-mir-324 is a type of microRNA that has been implicated in the progression of triple-negative breast cancer (TNBC) [PMC4633580]. A study identified three miRNAs associated with TNBC progression pathways, including hsa-mir-324 [PMC4633580]. However, this study did not integrate these miRNAs with TNBC genes alone or compare them to normal tissue or lymph node metastases [PMC4633580]. Another study found that 4-AAQB enhanced the anticancer effect of FOLFOX by re-expressing hsa-mir-324 inhibited by SOD2 and suppressing SOD2-mediated tumorigenicity [PMC9164036].